The State government has appointed IPS officer (retd) Ashit Mohan Prasad as Chief Information Commissioner, besides appointing seven Information Commissioners. IAS officer (retd) Mamatha B.R ...

alleging the involvement of former Raptadu MLA Topudurthi Prakash Reddy's brothers, Rajashekara Reddy and Chandra Reddy. Malli Reddy told media that his son received death threats from Rajashekara ...

Vijayasai, who had a successful career as a chartered accountant with offices in several cities, had been close to the YSR family since 1980 when he first met Dr Y S Rajashekara Reddy, Jagan’s father ...

“We are not sure why he has taken this drastic step,” the source said. Reddy’s association with Jagan’s family traces back to when his father Y S Rajashekara Reddy was in power. Vijayasai was the ...

Telangana Chief Minister Revanth Reddy discussed the state's investment progress. He aims for projects worth Rs 1 lakh crore this year, highlighting Hyderabad's appeal to global investors and its ...

The policies adopted by Chandrabrababu and YS Rajasekhara Reddy helped the extraordinary development of the state and Hyderabad, he said. "Former CM YS Rajashekara Reddy and current AP CM Chandrababu ...

Pharmaceutical major Dr Reddy's Laboratories is slated to release its October-December earnings report on January 23. Marking a shift from previous quarters of solid growth, the company's net ...

Reddy Customs, an automotive customization company, introduced four vehicle modifications at the Bharat Mobility Global Expo 2025 in New Delhi. The showcase includes a Mercedes G-Wagon, a Mercedes ...

The ‘TelanganaRising’ delegation led by Chief Minister A. Revanth Reddy landed in Zurich, Switzerland on Monday (January 20, 2025) morning after their successful visit to Singapore.

Indian pharmaceutical major, Dr Reddy’s Laboratories, is scheduled to deliver its October-December quarterly earnings for the financial year 2024-25 (Q3FY25) on Thursday, January 23, 2025. According ...

BofA has chosen Dr. Reddy's Laboratories Ltd. as its top pick in the Indian pharma space, as its sees earnings visibility in the near term. Two years of outperformance-boosted valuation and gross ...